Acceleron Pharma To Participate In Four Healthcare Investor Conferences In March
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Acceleron Pharma Inc. (NASDAQ:XLRN), a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic candidates that regulate cellular growth and repair, today announced that senior management will participate in four upcoming healthcare investor conferences in March.